Dermatitis herpetiformis : Part II. Diagnosis, management, and prognosis - 10/08/11
Reprint requests: Vesna Petronic-Rosic, MD, MSc, Section of Dermatology, The University of Chicago, 5841 S Maryland Ave, MC5067, Chicago, IL 60637.Abstract |
The prompt recognition of the clinical features of dermatitis herpetiformis (DH) is important, but securing a definitive diagnosis requires further work-up. Recent advances in understanding of the immunologic basis for DH have led to the development and wider availability of serologic testing, which is rapidly becoming an essential part of the diagnosis and management of DH. Part II of this series will detail the diagnosis, treatment, and follow-up for patients with DH, and will particularly focus on recent advances in the field.
Le texte complet de cet article est disponible en PDF.Key words : autoimmune bullous disease, celiac disease, dapsone, dermatitis herpetiformis, enzyme-linked immunosorbent assay, gliadin, gluten-free diet, gluten-sensitive enteropathy, human leukocyte antigen–DQ2, human leukocyte antigen–DQ8, immunofluorescence, immunoglobulin A, sulfapyridine
Plan
| Funding sources: None. |
Vol 64 - N° 6
P. 1027-1033 - juin 2011 Retour au numéro
Article précédent
- American Board of Dermatology Examination Dates
- Answers to CME examination
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?